LAYQETA
LIVE

Serial Number

99637935

Owner

Glaxo Group Limited

Attorney

Elizabeth K. Rucki

Filing Date

Feb 6, 2026

Add to watchlist:

No watchlists yet
View on USPTO

LAYQETA Trademark

Serial Number: 99637935

LAYQETA is a trademark filed by Glaxo Group Limited on February 6, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Glaxo Group Limited (128 trademarks)

GSK Medicines Research Centre
Stevenage SG12NY , GB

Entity Type: 77

Trademark Details

Filing Date

February 6, 2026

Registration Date

Not Registered

Published for Opposition

June 30, 2026

Goods & Services

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 3, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 3, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 3, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 11, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 11, 2026 GNSL
SUSPENSION LETTER WRITTEN
Feb 11, 2026 CNSL
ASSIGNED TO EXAMINER
Feb 10, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 6, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2026 NWOS
NEW APPLICATION ENTERED
Feb 6, 2026 NWAP